Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Revive Therapeutics Ltd C.RVV

Alternate Symbol(s):  RVVTF

Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders. It is engaged in exploring the use of Bucillamine for the potential treatment of nerve agent exposure and long COVID. The Company, through its diagnostics division, is evaluating a point-of-care in vitro diagnostic device that aids in the detection of post COVID-19 conditions or Long COVID. It also advancing the development of Psilocybin-based therapeutics through various programs. The Company's subsidiaries include Revive Therapeutics Inc. (Ontario), Revive Diagnostics Inc., and Psilocin Pharma Corp. (Ontario).


CSE:RVV - Post by User

Bullboard Posts
Post by opsd1on Aug 01, 2020 12:38pm
273 Views
Post# 31353846

Comparing to SONA

Comparing to SONARVV could easily see a greater run than SONA has.

Look at the six month chart of SONA. It was also a penny stock around the beginning of the pandemic and is now above $14 with a market cap nearing $1 billion. But they are making testing kits. Yes, in high demand right now, but many other companies are doing that too. RVV has something special - a treatment for COVID-19! That is unique and much more valuable and much more likely to save lives. Having said that, RVV also now deserves a market cap of at least $1 billion, based on just the possibility that this next trail will be successful. It doesn't take a genius to figure this out - it's just logical.

And that simply puts the share price of RVV between $5 and $6. I know, seems like BS right now, but you know it is totally doable. The trick is to trade some on the way up, but keep your free shares for later. If the trial is successful, this company will be a household name, and worth many billions of dollars.
Bullboard Posts